BioCentury
ARTICLE | Company News

Lexicon and Arena in GPCR development

August 1, 2000 7:00 AM UTC

LEXG and ARNA will jointly discover and develop drug candidates to target G protein-coupled receptors (GPCRs). Each company will contribute an equal number of GPCRs, and use LEXG's functional genomics...